Reactions Weekly

, Volume 1230, Issue 1, pp 3–3 | Cite as

Bevacizumab: increased risk of venous thromboembolism

Review
  • 11 Downloads

Keywords

Public Health Systematic Review Relative Risk Randomise Control Trial Bevacizumab 

REFERENCE

  1. 1.
    Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S.Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA: the Journal of the American Medical Association 300: 2277-2285, No. 19, 19 Nov 2008Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations